Abiopharma

New Form 11-K - NEOGEN CORP Filed: 2025-06-24 AccNo: 0000950170-25-089430 Size: 3 MB

New Form 11-K - WATERS CORP /DE/ Filed: 2025-06-24 AccNo: 0001193125-25-145691 Size: 131 KB

FDA approve DATOPOTAMAB DERUXTECAN-DLNK

Healthy Extracts Launches STAT10™, Breakthrough CoQ10 and NutrientSupport Formulation for America’s 40 Million Statin Users

New Form 6-K - TRINITY BIOTECH PLC Filed: 2025-06-24 AccNo: 0001178913-25-002220 Size: 160 KB

Best Mid-Range Graphics Cards in 2025: Top Picks

The Top Rated VR Games On Steam (2025)

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Pokimane: Health Update And The Latest On What She’s Up To

New Form 8-K - InMed Pharmaceuticals Inc. Filed: 2025-06-24 AccNo: 0001213900-25-057139 Size: 269 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

FDA Approves Expanded Indications for GEHealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’sPatients

FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

Facebook Marketplace in 2025: Key Shifts and Opportunities

Axim Biotechnologies Files Pre-Submission with FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test